The Office of Digital Transformation (ODT) provides the vision and leadership in information technology (IT), data, and cybersecurity needed to advance FDA’s...

What is oral immunotherapy for food allergy? Oral immunotherapy (OIT) refers to feeding an allergic individual an increasing amount of an allergen with the goal of increasing the threshold …

In January 2020, an OIT treatment for peanut allergy received approval from the U.S. Food and Drug Administration (FDA). Palforzia® – developed by Aimmune Therapeutics and previously …

Oral immunotherapy is a medical treatment in which an individual who is allergic to a specific food consumes an increasing amount of the allergen with the goal of reducing the risk of...

Peanut oral immunotherapy (OIT) with peanut allergen powder-dnfp (Palforzia ®) is an FDA-approved treatment for children ages 4 to 17 years that can help reduce the risk and severity …

2025年3月1日 · In the first head-to-head trial comparing Xolair to OIT, the study met its primary endpoint showing 36% of food allergy patients treated with Xolair monotherapy could tolerate …

2025年3月10日 · Today, there is only one FDA-approved OIT treatment (Palforzia), and it only treats peanut allergy. ADP101 is a novel, pharmaceutical-grade OIT candidate from Alladapt …

Peanut oral immunotherapy (OIT) is one of the most investigated alternative options with a recent United States Food and Drug Administration (FDA) approval in early 2020 for a peanut OIT …

Food immunotherapy involves gradual administration of increasing doses or fixed doses of the specific allergen daily with the aim to increase the clinical reaction threshold. Food allergy …

The U.S. Food and Drug Administration (FDA) approved the peanut OIT product Palforzia® (formerly known as AR101) in January 2020. The arrival on the market of an FDA-approved …